Article

Low-level smoking among Spanish-speaking Latino smokers: Relationships with demographics, tobacco dependence, withdrawal, and cessation

Department of Health Disparities Research, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77230-1402, USA.
Nicotine & Tobacco Research (Impact Factor: 2.81). 02/2009; 11(2):178-84. DOI: 10.1093/ntr/ntn021
Source: PubMed

ABSTRACT Although recent research indicates that many Latino smokers are nondaily smokers or daily smokers who smoke at a low level (<or =5 cigarettes/day), almost no research has investigated the characteristics of low-level smokers because such individuals are typically excluded from clinical trial research.
The present study examined the associations of daily smoking level and demographics, tobacco dependence, withdrawal, and abstinence during a specific quit attempt among 280 Spanish-speaking Latino smokers (54% male) who participated in a clinical trial of a telephone counseling intervention. Daily smokers were classified as low-level (1-5 cigarettes/day; n = 81), light (6-10 cigarettes/day; n = 99), or moderate/heavy smokers (> or =11 cigarettes/day; n = 100). Data were collected prior to the quit attempt and at 5 and 12 weeks postquit.
Results yielded three key findings. First, smoking level was positively associated with the total score and 12 of 13 subscale scores on a comprehensive, multidimensional measure of tobacco dependence. Low-level smokers consistently reported the least dependence, and moderate/heavy smokers reported the most dependence on tobacco. Second, low-level smokers reported the least craving in pre- to postcessation longitudinal analyses. Third, despite significant differences on dependence and craving, low-level smoking was not associated with abstinence. Smoking level was not associated with demographic variables.
This is a preliminary step in understanding factors influencing tobacco dependence and smoking cessation among low-level Spanish-speaking Latino smokers, a subgroup with high prevalence in the Latino population.

Download full-text

Full-text

Available from: Darla Kendzor, Aug 13, 2015
1 Follower
 · 
134 Views
  • Source
    • "almost uninterrupted smoking and important dependence may have made it seem impossible for them to give up smoking, thus explaining their concern for withdrawal and relapse. As illustrated in previous work, light smokers attempting to quit do experience craving and withdrawal symptoms, albeit less often than heavy smokers (Businelle, et al., 2009; Reitzel, et al., 2009). Nevertheless, research on short-term as well as long-term cessation has established that symptoms of craving decrease with time since the quit date (Schlam, Piper, Cook, Fiore, & Baker, 2012; Weinberger, Krishnan-Sarin, Mazure, & McKee, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study investigated perceived risks to cessation expressed by light smokers and the association with cessation outcomes at one month post-quit date. Data from adult light smokers attending French smoking cessation services nationwide between October 2007 and December 2010 were analyzed, retrospectively. In order to identify perceived risks, we performed a thematic analysis of answers to an open-ended question. Bivariate analysis and multivariate logistic modelling were used to assess predictors of abstinence and relapse. Eleven themes were identified, among which weight concerns were the most important for women while men cited withdrawal most often. A protective effect of NRT prescription on cessation was uncovered among men concerned about withdrawal as well as weight-concerned women. Fear of depression and need for moral support doubled the odds of relapse for women only. Considering the growing prevalence of light smokers in the general population, our findings suggest the importance of taking into account perceived risks to quitting. Without adapted treatment and counselling, they represent significant barriers to abstinence for treatment seeking light smokers.
    Preventive Medicine 06/2013; 57(4). DOI:10.1016/j.ypmed.2013.06.020 · 2.93 Impact Factor
  • Source
    • "The Clinical Practice Guidelines specifically call for additional evaluation of treatment for lower-level smokers, given that few pharmacotherapy trials have included light smokers (e.g., those who smoke 10 or fewer cigarettes per day) (Fiore, 2008). Compared to non-Hispanic white smokers, multiple studies have found that Latino adults smoke fewer cigarettes per day (Perez-Stable et al., 2001; Reitzel et al., 2009; Tong, Ong, Vittinghoff, & Perez-Stable, 2006; Zhu, Pulvers, Zhuang, & Baezconde-Garbanati, 2007). While light smokers are less likely than heavy smokers to perceive an increased personal risk of tobacco-related disease, even intermittent smokers are at increased risk for major tobaccorelated morbidity and mortality (Schane, Ling, Glantz, 2010; Ayanian & Cleary, 1999). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Smoking is the leading preventable cause of disease and death for U.S. Latinos. This study identified correlates of interest in participating in a smoking cessation program among urban Latinos seen in community clinics. Interviews were completed with 141 current smokers. Participants were predominantly Spanish-speaking (93%) males (66%), who were on average 37.6 years old and smoked 8.7 cigarettes per day. Over two-thirds (63%) of participants were "definitely interested" in participating in a smoking cessation program. Participants who smoked more cigarettes per day and reported greater nicotine dependence, depression, and readiness to quit were more likely to be interested, while those employed fulltime were less likely to report high interest. Treatment preferences were consistent with Clinical Practice Guidelines recommending counseling, social support, and pharmacotherapy. Results support recommendations that healthcare providers intervene with all Latino smokers, including light smokers and those who do not report initial interest in smoking cessation.
    Journal of Clinical Psychology in Medical Settings 12/2011; 18(4):392-9. DOI:10.1007/s10880-011-9259-y · 1.49 Impact Factor
  • Source
    • "The absence of a male–female difference in the count process of smoking involvement is an interesting addition to the growing literature on sex and gender differences in relation to smoking and drug taking generally (e.g., see Wagner & Anthony, 2007). As noted by others (e.g., Reitzel et al., 2009), light and "
    [Show abstract] [Hide abstract]
    ABSTRACT: Large-sample epidemiological studies of tobacco cigarette smoking routinely assess so-called "lifetime prevalence" of tobacco dependence. This work delves into the earliest stages of smoking involvement, focusing on newly incident tobacco cigarette smokers in the very recent past, and examines hypothesized subgroup variation in count processes that become engaged once smoking starts. Here, the term "count process" has two components: (a) whether smoking will be persistent and (b) the rate of smoking, conditional upon membership in a latent class of smokers who will persist, as estimated under the zero-inflated Poisson (ZIP) model for complex survey data. We estimate these ZIP parameters for nationally representative samples of newly incident smokers in the United States (all with smoking initiation within 24 months of assessment). Data are from the 2004-2007 National Surveys on Drug Use and Health. Once cigarette smoking started, roughly 40%-45% persisted, and the estimated median rate was five smoking days/30 days, conditional on membership in the latent class of persistent smokers. Among non-Hispanic recent-onset cigarette smokers, Whites, Black/African Americans, Asians, and Native American/Alaskan Natives did not differ, but recent-onset smokers of Hispanic origin and those of Pacific Islander background had comparatively less cigarette involvement. Tobacco prevention and control initiatives may require elaboration in the form of brief interventions, including interpersonal and social transactions that might constrain a mounting frequency of days of smoking before daily smoking starts, and until conventional smoking cessation medication aids become indicated. These very-early stage interventions (VESI) might be mounted within family or peer groups or in the primary care or school settings, but randomized trials to evaluate VESI interventions will be required.
    Nicotine & Tobacco Research 07/2010; 12(7):734-41. DOI:10.1093/ntr/ntq073 · 2.81 Impact Factor
Show more